Clinical Trial Update: Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial update for VB15010 tablets in advanced solid tumors; the study is currently recruiting across multiple cancer types.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Breast Cancer
• Colorectal Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• VB15010

Snippet

Sponsor: Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | Conditions: Cancer, Neoplasms | Phase 1, Phase 2 | Status: RECRUITING